Clinical Trials
2 trialsNCT05393713 2025-12-03
Intra-Lymphatic STI-3031 Using the Sofusa DoseConnect Device for Treatment of In-Transit Melanoma, The Sofusa-2 Study
Mayo Clinic
Phase 1 Terminated
NCT03644056 2020-05-28
Dose-escalation Study of IMC-001 in Subject With Metastatic or Locally-advanced Solid Tumors
ImmuneOncia Therapeutics Inc.
Phase 1 Completed